Stock Events

Omnicell 

€24.2
2
+€0+0% Friday 19:41

統計

當日最高
24.4
當日最低
24.2
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
1.22B
市盈率
-57.97
股息收益率
-
股息
-

收益

2May確認
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.09
0.27
0.64
1
預期每股收益
-0.09
實際每股收益
0.03

人們還關注

此列表基於在 Stock Events 上關注 OC9.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

32平均價格目標
最高估價為 €38。
來自過去 6 個月內的 2 個評級。這不是投資建議。
買入
50%
持有
50%
賣出
0%

關於

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Show more...
首席執行官
Mr. Randall A. Lipps
員工
3590
國家
US
ISIN
US68213N1090
WKN
000632313

上市公司